International AIDS Vaccine Initiative;Theraclone Sciences, Inc.;The Scripps Research Institute
发明人:
DOORES, Katherine,CHAN-HUI, Po-ying,HUBER, Michael,KAMINSKY, Stephen,FREY, Steven,OLSEN, Ole,MITCHAM, Jennifer,MOYLE, Matthew,PHOGAT, Sanjay K.,BURTON, Dennis R.,WALKER, Laura Marjorie,POIGNARD, Pasca
申请号：
AU2020203853
公开号：
AU2020203853A1
申请日:
2020.06.11
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020203853A120200702.pdf#####ABSTRACT The invention provides a method for obtaining a broadly neutralizing antibody (bNab), including screening memory B cell cultures from a donor PBMC sample for neutralization activity against a plurality of HIV-1 species, cloning a memory B cell that exhibits broad neutralization activity； and rescuing a monoclonal antibody from that memory B cell culture. The resultant monoclonal antibodies may be characterized by their ability to selectively bind epitopes from the Env proteins in native or monomeric form, as well as to inhibit infection of HIV-1 species from a plurality of clades. Compositions containing human monoclonal anti-HIVI antibodies used for prophylaxis, diagnosis and treatment of HIV infection are provided. Methods for generating such antibodies by immunization using epitopes from conserved regions within the variable loops of glp20 are provided. Immunogens for generating anti-HVI bNabs are also provided. Furthermore, method for vaccination using suitable epitopes are provided.
